Trzin, Slovenia

Tomaz Mesar

This inventor holds 1 USPTO granted patent. Top assignee: Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.d.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomaz Mesar. Retrieved from https://idiyas.com/inventor/tomaz-mesar-2x4ta3vn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tomaz Mesar

Introduction

Tomaz Mesar is a notable inventor based in Trzin, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on carbapenems. His dedication to research and development has led to the creation of valuable patents that enhance medical treatments.

Latest Patents

Tomaz Mesar holds a patent for "Ethylidene derivatives of tricyclic carbapenems." This invention represents a breakthrough in the development of antibiotic compounds, showcasing his expertise in medicinal chemistry. The patent highlights his commitment to advancing healthcare through innovative solutions.

Career Highlights

Mesar is currently employed at Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.d., a leading pharmaceutical company in Slovenia. His role at Lek allows him to collaborate with other talented professionals in the industry, furthering his impact on pharmaceutical innovations.

Collaborations

Tomaz Mesar has worked alongside esteemed colleagues such as Anton Copar and Tomaz Solmajer. Their collaborative efforts have contributed to the success of various projects within the company, fostering an environment of innovation and creativity.

Conclusion

Tomaz Mesar's contributions to the field of pharmaceuticals through his patent and collaborative work exemplify the spirit of innovation. His dedication to improving medical treatments continues to inspire others in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…